Q4 2020 Allogene Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Allogene Therapeutics Fourth Quarter and Year-end 2020 Conference Call. (Operator Instructions) Please be aware that this call is being recorded. I would now like to turn the conference call over to Christine Cassiano, Chief Communications Officer. Ms. Cassiano, please go ahead.
Thank you, operator, and to all on the line, welcome to our first afternoon conference call. As we look ahead to the rest of 2021, we will now be conducting these calls in the afternoon, and we will continue to limit questions to 1 per person in order to answer all of your questions during the hour.
Aftermarket market closed today, (inaudible) our press release provides a corporate update and financial results for Q4 and full year of 2020. This press release and today's webcast are both available on our website. Joining me on the call today are Dr. David Chang, President and Chief Executive Officer; Dr. Rafael Amado,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |